Pay in installments of $4.88 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 18 - Jul 23
For Your Every Summer RSVP, with Code: SUMMER15
Description
Jonas Salk: A LifeWhen a waiting world learned on April 12, 1955, that Jonas Salk had successfully created a vaccine to prevent poliomyelitis, he became a hero overnight. Born in a New York tenement, humble in manner, Salk had all the makings of a twentieth century icon a knight in a white coat. In the wake of his achievement, he received a staggering number of awards and honors; for years his name ranked with Gandhi and Churchill on lists of the most revered people.
When a waiting world learned on April 12, 1955, that Jonas Salk had successfully created a vaccine to prevent poliomyelitis, he became a hero overnight. Born in a New York tenement, humble in manner, Salk had all the makings of a twentieth-century icon--a knight in a white coat. In the wake of his achievement, he received a staggering number of awards and honors; for years his name ranked with Gandhi and Churchill on lists of the most revered people. And yet the one group whose adulation he craved--the scientific community--remained ominously silent. "The worst tragedy that could have befallen me was my success," Salk later said. "I knew right away that I was through--cast out." In the first complete biography of Jonas Salk, Charlotte DeCroes Jacobs unravels Salk's story to reveal an unconventional scientist and a misunderstood and vulnerable man. Despite his incredible success in developing the polio vaccine, Salk was ostracized by his fellow scientists, who accused him of failing to give proper credit to other researchers and scorned his taste for media attention. Even before success catapulted him into the limelight, Salk was an inscrutable man disliked by many of his peers. Driven by an intense desire to aid mankind, he was initially oblivious and eventually resigned to the personal cost--as well as the costs suffered by his family and friends. And yet Salk remained, in the eyes of the public, an adored hero. Based on hundreds of personal interviews and unprecedented access to Salk's sealed archives, Jacobs' biography offers the most complete picture of this complicated figure. Salk's story has never been fully told; until now, his role in preventing polio has overshadowed his part in co-developing the first influenza vaccine, his effort to meld the sciences and humanities in the magnificent Salk Institute, and his pioneering work on AIDS. A vivid and intimate portrait, this will become the standard work on the remarkable life of Jonas Salk.Binding Type: Paperback
Publisher: Oxford University Press, USA
Published: 12/01/2017
ISBN: 9780190679163
Pages: 576
Weight: 1.37lbs
Size: 8.20h x 5.50w x 1.50d
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.2 ★★★★★
Based on 26 reviews
Sort
Product Reviews
★★★★★ 5
Great shoes!
Size: 5 Big Kid, Color: Light Grass Green
This is my second time purchasing these shoes!
Not only are they stylish and well made, but they are comfortable! These have been used as running shoes, they have great support and suitable for long distances. The fit is true to size.
Thank you!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 16, 2026
★★★★★ 4
Shoe laces aren't great.
Size: 3 Big Kid, Color: Black White
I bought these RUNSIDE kids tennis shoes for everyday wear and school, and overall they’re lightweight, breathable, and comfortable for active use. My child liked how easy they were to put on, and they worked well for running and general play.
The shoes themselves feel flexible and pretty comfortable for the price point. The upper material is breathable, which helps during sports or warmer weather, and they don’t feel heavy on the feet.
However, the main issue is the original shoelaces. They constantly came untied no matter how they were tied, which became frustrating pretty quickly during the day. We ended up replacing them with better-quality laces, and that solved the problem.
Pros:
* Lightweight and comfortable for kids
* Breathable material works well for active use
* Easy for everyday wear and school
* Good fit for the price
Cons:
* Original shoelaces do not stay tied well
* Laces needed to be replaced for practical use
Overall, these are solid budget-friendly kids’ sneakers that work well once the laces are swapped out. The shoe itself is comfortable and functional, but the included laces are definitely a weak point.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on June 4, 2026
★★★★★ 5
Great shoes
Size: 8 Toddler, Color: Camouflage Gray
Bought these for my three-year-old son, they fit great and they are easy for him to slide on himself. The laces seem to come untied a lot, but otherwise we love them!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 8, 2026
★★★★★ 5
Perfect for Active Kids
Size: 4 Big Kid, Color: Black, Size: 4 Big Kid, Color: Black
My son loves these shoes. He says they’re really comfortable and lightweight, and he can run and play in them easily. So far they’ve held up well. He can fit them. Non Velcro and slip resistant.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 2, 2026
★★★★★ 3
Good, but not great! Insert kept falling out.
Size: 3 Big Kid, Color: Black
I bought these for my 8 year old and the insert was loose and had to be played with multiple times before I could get it to stay in place. I eventually had to place a double sided sticky pad to get the insert to stay.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on June 8, 2026